Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions

被引:94
作者
Godkin, AJ
Smith, KJ
Willis, A
Tejada-Simon, MV
Zhang, JW
Elliott, T
Hill, AVS
机构
[1] Univ Oxford, Inst Mol Med, Mol Immunol Grp, Nuffield Dept Med,John Radcliffe Hosp, Oxford, England
[2] Childrens Hosp, Howard Hughes Med Inst, Mol Med Lab, Dept Med, Boston, MA 02115 USA
[3] MRC, Immunochem Unit, Dept Biochem, Oxford, England
[4] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA
[5] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W2 1PG, England
关键词
D O I
10.4049/jimmunol.166.11.6720
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
MHC class II heterodimers bind peptides 12-20 aa in length. The peptide flanking residues (PFRs) of these ligands extend from a central binding core consisting of nine amino acids. Increasing evidence suggests that the PFRs can alter the immunogenicity of T cell epitopes. We have previously noted that eluted peptide pool sequence data derived from an MHC class II Ag reflect patterns of enrichment not only in the core binding region but also in the PFRs. We sought to distinguish whether these enrichments reflect cellular processes or direct MHC-peptide interactions. Using the multiple sclerosis-associated allele HLA-DR2, pool sequence data from naturally processed ligands were compared with the patterns of enrichment obtained by binding semicombinatorial peptide libraries to empty HLA-DR2 molecules. Naturally processed ligands revealed patterns of enrichment reflecting both the binding motif of HLA-DR2 (position (P)1, aliphatic; P4, bulky hydrophobic; and P6, polar) as well as the nonbound flanking regions, including acidic residues at the N terminus and basic residues at the C terminus. These PFR enrichments were independent of MHC-peptide interactions. Further studies revealed similar patterns in nine other HLA alleles, with the C-terminal basic residues being as highly conserved as the previously described N-terminal prolines of MHC class It ligands. There is evidence that addition of C-terminal basic PFRs to known peptide epitopes is able to enhance both processing as well as T cell activation. Recognition of these allele-transcending patterns in the PFRs may prove useful in epitope Identification and vaccine design. The Journal of Immunology, 2001.
引用
收藏
页码:6720 / 6727
页数:8
相关论文
共 36 条
[1]   Substrate specificity of cathepsins D and E determined by N-terminal and C-terminal sequencing of peptide pools [J].
Arnold, D ;
Keilholz, W ;
Schild, H ;
Dumrese, T ;
Stevanovic, S ;
Rammensee, HG .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 249 (01) :171-179
[2]   T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage [J].
Carson, RT ;
Vignali, KM ;
Woodland, DL ;
Vignali, DAA .
IMMUNITY, 1997, 7 (03) :387-399
[3]  
Cope AP, 1999, ARTHRITIS RHEUM, V42, P1497, DOI 10.1002/1529-0131(199907)42:7<1497::AID-ANR25>3.0.CO
[4]  
2-#
[5]  
DAVENPORT MP, 1995, IMMUNOGENETICS, V42, P392
[6]   NATURALLY PROCESSED PEPTIDES FROM 2 DISEASE-RESISTANCE-ASSOCIATED HLA-DR13 ALLELES SHOW RELATED SEQUENCE MOTIFS AND THE EFFECTS OF THE DIMORPHISM AT POSITION-86 OF THE HLA-DR-BETA CHAIN [J].
DAVENPORT, MP ;
QUINN, CL ;
CHICZ, RM ;
GREEN, BN ;
WILLIS, AC ;
LANE, WS ;
BELL, JI ;
HILL, AVS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (14) :6567-6571
[7]   A distinctive peptide binding motif for HLA-DRBI*0407, an HLA-DR4 subtype not associated with rheumatoid arthritis [J].
Davenport, MP ;
Godkin, A ;
Friede, T ;
Stevanovic, S ;
Willis, AC ;
Hill, AVS ;
Rammensee, HG .
IMMUNOGENETICS, 1997, 45 (03) :229-232
[8]   X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II [J].
Dessen, A ;
Lawrence, CM ;
Cupo, S ;
Zaller, DM ;
Wiley, DC .
IMMUNITY, 1997, 7 (04) :473-481
[9]  
FALK K, 1994, IMMUNOGENETICS, V39, P230
[10]   New ligands binding to the human leukocyte antigen class II molecule DRB1(*)0101 based on the activity pattern of an undecapeptide library [J].
Fleckenstein, B ;
Kalbacher, H ;
Muller, CP ;
Stoll, D ;
Halder, T ;
Jung, G ;
Wiesmuller, KH .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 240 (01) :71-77